Clinical Negligence Solicitors

Scientists at University College London (UCL) say they are closer to understanding the genetic causes of Type 2 diabetes by identifying 111 new chromosome locations (“loci”) on the human genome that indicate susceptibility to the disease.

In collaboration with colleagues at Imperial College London, the team used a method developed at UCL, based on highly informative genetic maps to investigate complex disorders such as Type 2 diabetes

Type 2 diabetes is the world’s most widespread and devastating metabolic disorder – and previously only 76 loci were known and studied.

Very few these loci are found in the African American population, where the prevalence of Type 2 diabetes is almost twice that of the European American population –19% disease prevalence compared with 10%, respectively.

Of the additional 111 loci identified by the team, 93 (84%) are found in both African American and European populations – and only 18 loci are European-specific.

The study published in The American Journal of Human Genetics involves European and African American sample populations comprising 5,800 Type 2 diabetes case subjects and 9,691 control subjects – and reveals multiple Type 2 diabetes loci at regulatory hotspots across the genome.

Lead author, Dr Nikolas Maniatis (UCL Genetics, Evolution & Environment) said.

“No disease with a genetic predisposition has been more intensely investigated than Type 2 diabetes.

“We’ve proven the benefits of gene mapping to identify hundreds of locations where causal mutations might be across many populations, including African Americans.

“This provides a larger number of characterised loci for scientists to study and will allow us to build a more detailed picture of the genetic architecture of Type 2 diabetes.”

Co-lead author, Dr Toby Andrew (Imperial College London, Department of Genomics of Common Disease) added:

“Before we can conduct the functional studies required in order to better understand the molecular basis of this disease, we first need to identify as many plausible candidate loci as possible.

“Genetic maps are key to this task, by integrating the cross-platform genomic data in a biologically meaningful way.”

The team discovered that the additional 111 loci and previously known 76 loci regulate the expression of at least 266 genes that neighbour the identified disease loci.

The vast majority of these loci were found outside gene coding regions, but coincided with regulatory “hotspots” that alter the expression of these genes in body fat.

They are currently investigating whether these loci alter the expression of the same genes in other tissues – such as the pancreas, liver and skeletal muscle – that are also relevant to Type 2 diabetes.

The team analysed further three loci present in African American and European populations, using deep sequencing in an independent sample of 94 European patients with Type 2 diabetes and 94 control subjects, in order to identify genetic mutations that cause the disease.

The team found that all three loci overlapped with areas of the chromosome containing multiple regulatory elements and epigenetic markers, along with candidate causal mutations for Type 2 diabetes that can be further investigated.

Dr Winston Lau (UCL Genetics, Evolution & Environment) said:

“Our results mean that we can now target the remaining loci on the genetic maps with deep sequencing, to try and find the causal mutations within them.

“We are also very excited that most of the identified disease loci appear to confer risk of disease in diverse populations such as African Americans, implying our findings are likely to be universally applicable and not just confined to Europeans.”

Dr Maniatis added:

“We are now in a strong position to build upon these genomic results – and we can apply the same methods to other complex diseases, such as Alzheimer’s disease.”

Duncan Lewis Clinical Negligence Solicitors

Duncan Lewis Clinical Negligence Solicitors can advise those who have suffered injury as a result of negligence diabetes care or misdiagnosis on how to make a no win no fee claim for compensation.

Diabetes claims have to be made within three years of when negligence became evident. Children can make clinical negligence claims up to the age of 21.

Duncan Lewis also offers supportive legal advice to bereaved families whose loved one may have lost their life as a result of diabetes misdiagnosis or poor diabetes care and who wish to claim compensation.

For expert legal advice on no win no fee Diabetes Claims, call Duncan Lewis clinical negligence solicitors on 0333 772 0409.